Chronic inflammation of the skin can be induced in IgE transgenic mice by means of a single challenge of multivalent antigen.

BACKGROUND It is now widely accepted that IgE mediates immediate-type allergic response. However, the pathologic role of IgE is controversial in the chronic allergic inflammation observed in atopic diseases, such as asthma and atopic dermatitis. OBJECTIVE We investigated the role of IgE in cutaneous allergic reactions by using 2 newly developed lines of antigen-specific IgE transgenic mice. METHODS IgE transgenic mice were administered subcutaneously with corresponding antigens, and the subsequent ear swelling was measured. RESULTS A single subcutaneous administration of TNP-conjugated ovalbumin (OVA) into the ears of nonimmunized mice carrying the TNP-specific IgE transgene elicited immediate-phase and late-phase ear swelling as expected, which peaked at 20 minutes and 8 hours later, respectively. Interestingly, however, 2 to 3 days after the antigen challenge, more intense ear swelling appeared. Its magnitude and duration were dependent on the valency of TNP in OVA, as well as the dose of TNP-OVA, and it lasted over 1 month when 100 microg of OVA conjugated with 11 molecules of TNP was given. Interestingly, administration of OVA to OVA-specific IgE transgenic mice elicited immediate-phase and late-phase ear swelling but not third-phase ear swelling. Massive infiltration of inflammatory cells was observed in the third-phase ear swelling of TNP-specific IgE transgenic mice. Cyclosporine A almost completely inhibited the third-phase ear swelling and cellular infiltration, whereas an antihistamine, cyproheptadine, did not show any significant effect on the third-phase reaction. CONCLUSION These results indicate that IgE can trigger not only immediate-type hypersensitivity but also chronic allergic inflammation. Our findings highlight a novel immunopathologic role of IgE in chronic atopic disorders.

[1]  E. Schulman,et al.  Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders. , 2001, American journal of respiratory and critical care medicine.

[2]  H. Sampson,et al.  IgE and IgG Binding Epitopes on α-Lactalbumin and β-Lactoglobulin in Cow’s Milk Allergy , 2001, International Archives of Allergy and Immunology.

[3]  R. Geha,et al.  IgE regulation and roles in asthma pathogenesis. , 2001, The Journal of allergy and clinical immunology.

[4]  M. Schlaak,et al.  Discontinuous IgE‐binding epitopes contain multiple continuous epitope regions: results of an epitope mapping on recombinant Hol l 5, a major allergen from velvet grass pollen , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  I. Saiki,et al.  A third-phase cutaneous (very late phase) response after elicitation with dinitrofluorobenzene in passively or actively sensitized mice , 2000 .

[6]  G. Mancuso,et al.  Long‐lasting allergic patch test reactions: a study of patients with positive standard patch tests , 1999, Contact dermatitis.

[7]  H. Yonekawa,et al.  Establishment of antigen-specific IgE transgenic mice to study pathological and immunobiological roles of IgE in vivo. , 1999, International immunology.

[8]  J. Naeyaert,et al.  Cyclosporin in Atopic Dermatitis , 1999, Dermatology.

[9]  S. Holgate,et al.  Mast cell derived mediators , 1998 .

[10]  D. Metcalfe,et al.  Lymphotactin gene expression in mast cells following Fc(epsilon) receptor I aggregation: modulation by TGF-beta, IL-4, dexamethasone, and cyclosporin A. , 1997, Journal of immunology.

[11]  M. Nakanishi,et al.  Quantitative and realtime correlation between receptor aggregation and intracellular calcium signal transduction. , 1996, Immunology letters.

[12]  S. Schreiber,et al.  Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Ishizaka,et al.  Identification of gamma-E-antibodies as a carrier of reaginic activity. , 1967, Journal of immunology.

[14]  C. Williams Methods in Immunology and Immunochemistry , 1967 .